Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $120.70 | Total: $603.50 |
| 1 | 10 | $102.24 | Total: $1,022.40 |
| 1 | 25 | $86.62 | Total: $2,165.50 |
| 1 | 50 | $73.84 | Total: $3,692.00 |
| 1 | 100 | $63.90 | Total: $6,390.00 |
Overview
Difelikefalin acetate (CR 845 acetate) is a peripherally restricted kappa opioid receptor agonist. CR845 exhibit low P450 CYP inhibition and low penetration into the brain.
Chemical Properties
| Molecular Formula | C38H57N7O8 |
| Molecular Weight | 739.9 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CC(C[C@H](C(N[C@@H](C(N1CCC(CC1)(C(O)=O)N)=O)CCCCN)=O)NC([C@H](NC([C@@H](Cc2ccccc2)N)=O)Cc3ccccc3)=O)C.CC(O)=O |
Storage and Handling
0C Short Term, -20C Long Term
References
Shram MJ, Spencer RH, et al. Evaluation of the abuse potential of difelikefalin, a selective kappa-opioid receptor agonist, in recreational polydrug users. Clin Transl Sci. 2022 Feb;15[2] 535-547.